Natera, Inc. is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA testing technology, with a focus on women’s health, cancer, and organ health.
Looks like some consolidation in a fixed range from March this year.
A break of $41,60 level would be considered bullish with a possible gap close target of $52.50
Looks like some consolidation in a fixed range from March this year.
A break of $41,60 level would be considered bullish with a possible gap close target of $52.50